Atlas Trials

A Thorough QTc Evaluation of the Effect of Semaglutide on Cardiac Repolarisation in Healthy Subjects

Clinical trial NCT02064348 · COMPLETED

Trial details

NCT number
NCT02064348
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
DiabetesHealthy
Start date
2014-02-26
Primary completion
2015-04-23
Enrollment
168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.